#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastric cancer Glycogen storage disease type II Red blood cell abnormality Carcinoid tumour Marginal zone lymphoma Squamous cell carcinoma of the oral cavity Heritable pulmonary arterial hypertension Primary hyperoxaluria Chronic inflammatory demyelinating polyradiculoneuropathy Laryngeal squamous cell carcinoma Acute myeloid leukaemia Cardiomyopathy Chronic graft versus host disease Paroxysmal nocturnal haemoglobinuria Malignant oligodendroglioma More trials…

    Learn about Rare Diseases

    Leiomyosarcoma Atypical teratoid/rhabdoid tumour of CNS – Basic Information X-linked lymphoproliferative syndrome – Basic Information Myelodysplastic syndrome – Trials in Disease Kearns-Sayre syndrome – Life with Disease Soft tissue sarcoma – Treatment Pituitary-dependent Cushing’s syndrome – Life with Disease Hereditary angioedema – Treatment Primary biliary cholangitis – Life with Disease Encephalitis autoimmune – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Paclitaxel Obaluronate Famotidine MEGESTROL ACETATE Maralixibat Chloride Gozetotide Alf-18 Sertraline Coffee Charcoal FG001 Metformin Clofutriben Ep0031 Protein C Co-Trimoxazole Dasatinib CC-97540 Nizaracianine Triflutate Psma-11 Heparin L-Histidine Hydrochloride Fluorescein Sodium More therapies…

    Learn about Your Condition

    Periodontitis Tricuspid valve disease Nephrotic syndrome Intervertebral disc protrusion Eye disorder Pulmonary vascular disorder Pituitary tumour benign Essential hypertension Eosinophilic oesophagitis Liposarcoma recurrent Decreased appetite Vulvovaginal candidiasis Hypercholesterolaemia Malignant melanoma of eyelid Atopic keratoconjunctivitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2ks Bibpcuhoj Dx Sggcte Mpdhwwlmflw Bm 1yvw Mwddafaobd 1matcq Fmpxpg

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Drug Combination Treatment Based on Tumor Molecular Changes in Patients with Advanced or Metastatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Siremadlin
    • Cabozantinib
    • Dabrafenib
    France

  • Study of valemetostat tosylate tablets in patients with relapsed or refractory B-cell lymphoma, including aggressive B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Hodgkin lymphoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • B-cell lymphoma refractory
    Investigated Drugs:
    • Valemetostat Tosilate
    Belgium France

  • Study of Pioglitazone and Avelumab Combined with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients with Complete Cytogenetic Response

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Pioglitazone
    • Avelumab
    France

  • Study on Stopping or Continuing Anastrozole, Letrozole, and Exemestane for Patients with Advanced or Metastatic Low-Grade Endometrial Stromal Sarcoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    France

  • Study on Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Patients with Recurrent Ovarian Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Cisplatin
    France

  • Study on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Saruparib
    • Abemaciclib
    • Anastrozole
    Austria Bulgaria Czechia France Germany Hungary +4

  • Evaluation of drug combination therapy (olaparib, nilotinib, tremelimumab, and durvalumab) for patients with advanced or metastatic solid tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic neoplasm
    Investigated Drugs:
    • Nilotinib
    • Durvalumab
    • Olaparib
    France

  • Study of Pembrolizumab with Chemotherapy for Patients with HER2-Negative Inflammatory Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Cyclophosphamide
    • Paclitaxel
    France

  • Study of Asciminib treatment for patients with Chronic Myeloid Leukemia who have T315I mutation and cannot take or tolerate ponatinib

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Asciminib Hydrochloride
    France

  • Comparison of ruxolitinib versus hydroxycarbamide or interferon alfa as first treatment for high-risk polycythemia vera patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Peginterferon Alfa-2A
    • Hydroxycarbamide
    • Ruxolitinib
    France
Previous Page
1 … 8 9 10 11 12 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!